Pharmaceutical Discovery and Preclinical Development1

 View Only
Back to discussions
Expand all | Collapse all

OSD on Wed. Jan 22, 2025 - Context of Use: Bridging Biomarker Strategy with Analytical Excellence (Part 2)Characterizing CD4 T Cell Immune Responses (Part 1)

  • 1.  OSD on Wed. Jan 22, 2025 - Context of Use: Bridging Biomarker Strategy with Analytical Excellence (Part 2)Characterizing CD4 T Cell Immune Responses (Part 1)

    Community Leadership
    Posted 12-08-2024 20:54

    Please join for the second Open Scientific Discussion (OSD) in the Biomarker Strategy series hosted by the AAPS Biomarkers and Precision Medicine (BPM) and Gene and Cell Therapy Products (GCTP) Communities on January 22nd, 12 – 1 pm EST on the following topic:

     

    Context of Use: Bridging Biomarker Strategy with Analytical Excellence (Part 2)

    • What transforms a good biomarker strategy into a great one?
    • How good does an assay need to be (where do we set the bar)?
    • How does one select the appropriate analytical platform for biomarker assessments?
    • Case studies of different context of use scenarios will be presented

    Discussion Leaders:

    • Yan Ni (Passage Bio)
    • Karen Quadrini (Prothena Biosciences)
    • Joel Mathews (Ionis Pharmaceuticals)

    Organized by:  Karen Quadrini (Prothena Biosciences), Carmen Fernández-Metzler (PharmaCadence), Ayuko Ota-Setlik (Regeneron)

     

    We start at 12:00 EST sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

    (Please remain on mute unless asking questions)

     

    When: Wednesday, Jan 22, 2025 12pm – 1pm EST

    Where: Please join from your computer, tablet or smartphone.
    https://global.gotomeeting.com/join/305789893

    You can also dial in using your phone.
    United States:     +1 (872) 240-3412
    Access Code: 305-789-893

    Join from a video-conferencing room or system.
    Dial in or type:     67.217.95.2 or inroomlink.goto.com
    Meeting ID: 305 789 893
    Or dial directly:     [email protected] or 67.217.95.2##305789893

    New to GoToMeeting? Get the app now and be ready when your first meeting starts:
    https://global.gotomeeting.com/install/305789893

     

    Please feel free to share with colleagues who may be interested in this topic.

     

    Thanks,

    On Behalf of The Leadership Teams of the AAPS BPM and GCTP Communities

    #biomarker  #OSD  #Contextofuse  #OpenScientificDiscussions  #Bioanalytical



    ------------------------------
    Karen Quadrini, PhD
    Director, Clinical Biomarkers
    Prothena Biosciences
    Brisbane, CA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------